company background image
ADR logo

Adherium CHIA:ADR Stock Report

Last Price

AU$0.007

Market Cap

AU$5.3m

7D

0%

1Y

-61.1%

Updated

22 May, 2025

Data

Company Financials

ADR Stock Overview

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. More details

ADR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Adherium Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Adherium
Historical stock prices
Current Share PriceAU$0.007
52 Week HighAU$0.029
52 Week LowAU$0.007
Beta1.51
1 Month Change-12.50%
3 Month Change-41.67%
1 Year Change-61.11%
3 Year Change-94.81%
5 Year Change-98.21%
Change since IPO-99.92%

Recent News & Updates

Recent updates

Shareholder Returns

ADRAU Healthcare ServicesAU Market
7D0%4.4%1.1%
1Y-61.1%125.2%5.0%

Return vs Industry: ADR underperformed the Australian Healthcare Services industry which returned 125.2% over the past year.

Return vs Market: ADR underperformed the Australian Market which returned 5% over the past year.

Price Volatility

Is ADR's price volatile compared to industry and market?
ADR volatility
ADR Average Weekly Movementn/a
Healthcare Services Industry Average Movement11.6%
Market Average Movement9.6%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market4.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine ADR's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001n/an/awww.adherium.com

Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.

Adherium Limited Fundamentals Summary

How do Adherium's earnings and revenue compare to its market cap?
ADR fundamental statistics
Market capAU$5.31m
Earnings (TTM)-AU$11.33m
Revenue (TTM)AU$964.13k
5.5x
P/S Ratio
-0.5x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ADR income statement (TTM)
RevenueAU$964.13k
Cost of RevenueAU$733.62k
Gross ProfitAU$230.51k
Other ExpensesAU$11.56m
Earnings-AU$11.33m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.015
Gross Margin23.91%
Net Profit Margin-1,174.67%
Debt/Equity Ratio48.3%

How did ADR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 03:29
End of Day Share Price 2025/05/20 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adherium Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Dennis HulmeEdison Investment Research
Chris KallosMST Financial Services Pty Limited